Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 10 years by 8.15% on an annualized basis producing an average annual return of 19.8%. Currently, Edwards Lifesciences has a market capitalization of $62.66 billion.
CNM-Au8® , a catalytically active gold nanocrystal suspension, significantly improved brain energetic metabolism in Parkinson’s patients
SALT LAKE CITY, Sept. 17, 2021 (GLOBE NEWSWIRE) -- Clene Inc.